- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 212819, 7 pages
Explanting Is an Ex Vivo Model of Renal Epithelial-Mesenchymal Transition
1Department of Nephrology, The Royal Melbourne Hospital, Melbourne, VIC 3050, Australia
2School of Medical Sciences, RMIT University, Melbourne, VIC 3083, Australia
3Department of Medicine, The University of Melbourne, Melbourne, VIC 3010, Australia
Received 23 June 2011; Revised 1 September 2011; Accepted 1 September 2011
Academic Editor: Nick Di Girolamo
Copyright © 2011 Catherine E. Winbanks et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. A. Eddy, “Progression in chronic kidney disease,” Advances in Chronic Kidney Disease, vol. 12, no. 4, pp. 353–365, 2005.
- T. D. Hewitson, “Renal tubulointerstitial fibrosis: common but never simple,” American Journal of Physiology, vol. 296, no. 6, pp. F1239–F1244, 2009.
- I. Darby, O. Skalli, and G. Gabbiani, “α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing,” Laboratory Investigation, vol. 63, no. 1, pp. 21–29, 1990.
- T. D. Hewitson and G. J. Becker, “Interstitial myofibroblasts in IgA glomerulonephritis,” American Journal of Nephrology, vol. 15, no. 2, pp. 111–117, 1995.
- M. Iwano, A. Fischer, H. Okada et al., “Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts,” Molecular Therapy, vol. 3, no. 2, pp. 149–159, 2001.
- Y. Liu, “New insights into epithelial-mesenchymal transition in kidney fibrosis,” Journal of the American Society of Nephrology, vol. 21, no. 2, pp. 212–222, 2010.
- M. Iwano, D. Plieth, T. M. Danoff, C. Xue, H. Okada, and E. G. Neilson, “Evidence that fibroblasts derive from epithelium during tissue fibrosis,” Journal of Clinical Investigation, vol. 110, no. 3, pp. 341–350, 2002.
- K. Jinde, D. J. Nikolic-Paterson, X. R. Huang et al., “Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis,” American Journal of Kidney Diseases, vol. 38, no. 4, pp. 761–769, 2001.
- Y. Y. Ng, T. P. Huang, W. C. Yang et al., “Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats,” Kidney International, vol. 54, no. 3, pp. 864–876, 1998.
- S. E. Quaggin and A. Kapus, “Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition,” Kidney International, vol. 80, no. 1, pp. 41–50, 2011.
- M. Zeisberg and J. S. Duffield, “Resolved: EMT produces fibroblasts in the kidney,” Journal of the American Society of Nephrology, vol. 21, no. 8, pp. 1247–1253, 2010.
- B. D. Humphreys, S. L. Lin, A. Kobayashi et al., “Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis,” American Journal of Pathology, vol. 176, no. 1, pp. 85–97, 2010.
- J. P. Thiery and J. P. Sleeman, “Complex networks orchestrate epithelial-mesenchymal transitions,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131–142, 2006.
- G. Prindull and D. Zipori, “Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm,” Blood, vol. 103, no. 8, pp. 2892–2899, 2004.
- T. D. Hewitson, M. G. Tait, K. J. Kelynack, M. Martic, and G. J. Becker, “Dipyridamole inhibits in vitro renal fibroblast proliferation and collagen synthesis,” Journal of Laboratory and Clinical Medicine, vol. 140, no. 3, pp. 199–208, 2002.
- T. D. Hewitson, K. J. Kelynack, M. G. Tait et al., “Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis,” Journal of Nephrology, vol. 14, no. 6, pp. 453–460, 2001.
- F. G. Silva, T. Nadasdy, and Z. Laszik, “Immunohistochemical and lectin dissection of the human nephron in health and disease,” Archives of Pathology and Laboratory Medicine, vol. 117, no. 12, pp. 1233–1239, 1993.
- L. D. Truong, V. T. Phung, Y. Yoshikawa, and C. A. Mattioli, “Glycoconjugates in normal human kidney. A histochemical study using 13 biotinylated lectins,” Histochemistry, vol. 90, no. 1, pp. 51–60, 1988.
- S. E. Wong, C. E. Winbanks, C. S. Samuel, and T. D. Hewitson, “Lectin histochemistry for light and electron microscopy,” Methods in Molecular Biology, vol. 611, pp. 103–114, 2010.
- J. M. Lee, S. Dedhar, R. Kalluri, and E. W. Thompson, “The epithelial-mesenchymal transition: new insights in signaling, development, and disease,” Journal of Cell Biology, vol. 172, no. 7, pp. 973–981, 2006.
- Y. Khew-Goodall and C. Wadham, “A perspective on regulation of cell-cell adhesion and epithelial- mesenchymal transition: known and novel,” Cells Tissues Organs, vol. 179, no. 1-2, pp. 81–86, 2005.
- I. R. Gupta, M. Lapointe, and O. H. Yu, “Morphogenesis during mouse embryonic kidney explant culture,” Kidney International, vol. 63, no. 1, pp. 365–376, 2003.
- B. Boyer, G. C. Tucker, A. M. Valles, W. W. Franke, and J. P. Thiery, “Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells,” Journal of Cell Biology, vol. 109, no. 4, pp. 1495–1509, 1989.
- B. Hinz, S. H. Phan, V. J. Thannickal, A. Galli, M. L. Bochaton-Piallat, and G. Gabbiani, “The myofibroblast: one function, multiple origins,” American Journal of Pathology, vol. 170, no. 6, pp. 1807–1816, 2007.
- J. Yang and Y. Liu, “Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis,” American Journal of Pathology, vol. 159, no. 4, pp. 1465–1475, 2001.
- D. J. Dwivedi, G. Pino, A. Banh et al., “Matrix metalloproteinase inhibitors suppress transforming growth factor-β-induced subcapsular cataract formation,” American Journal of Pathology, vol. 168, no. 1, pp. 69–79, 2006.
- A. Masszi, L. Fan, L. Rosivall et al., “Integrity of cell-cell contacts is a critical regulator of TGF-β1-induced epithelial-to-myofibroblast transition: role for β-catenin,” American Journal of Pathology, vol. 165, no. 6, pp. 1955–1967, 2004.
- A. Masszi, P. Speight, E. Charbonney et al., “Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3,” Journal of Cell Biology, vol. 188, no. 3, pp. 383–399, 2010.
- P. C. Baer, U. W. Tunn, G. Nunez, J. E. Scherberich, and H. Geiger, “Transdifferentiation of distal but not proximal tubular epithelial cells from human kidney in culture,” Experimental Nephrology, vol. 7, no. 4, pp. 306–313, 1999.
- M. D. Oldfield, L. A. Bach, J. M. Forbes et al., “Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE),” Journal of Clinical Investigation, vol. 108, no. 12, pp. 1853–1863, 2001.
- J. W. G. V. Copeland, B. W. Beaumont, M. J. Merrilees, and H. L. Pilmore, “Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone,” Transplantation, vol. 83, no. 6, pp. 809–814, 2007.
- M. J. Butt, A. F. Tarantal, D. F. Jimenez, and D. G. Matsell, “Collecting duct epithelial-mesenchymal transition in fetal urinary tract obstruction,” Kidney International, vol. 72, no. 8, pp. 936–944, 2007.